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Percutaneous treatment of thrombosed primary arteriovenous contributing significantly to morbidity and hospitaliza-
hemodialysis access fistulae. tion in the dialysis patient [2]. In the past, the creation
Background. We reviewed the efficacy of percutaneous in- and preservation of the vascular access were primarilytervention in acute thrombotic occlusion of native arteriove-
the responsibility of the surgeon, and dialysis shuntnous (AV) fistulae for hemodialysis.
thrombosis was regularly corrected with surgical throm-Methods. Eight-one percutaneous procedures were per-
formed in 54 patients presenting with a clotted native dialysis bectomy. Over the last decade, vascular access complica-
fistula. There were 60 cases of a long-segment thrombosis of tions have been increasingly approached on a multidisci-
the fistula. In 20 cases, a small thrombus usually caused by an
plinary basis. Today, dialysis centers are often usingunderlying severe stenosis was observed. A proximal arterial
percutaneous interventions performed by the interven-occlusion was seen in one case. Treatment depended on clot
size and included balloon dilation (N 5 20), mechanical throm- tional radiologist in the management of hemodialysis
bectomy with various devices (N 5 58), as well as pharmaco- access-related problems. Currently, available percutane-
mechanical thrombolysis (N 5 3). ous treatment regimens for thrombosed dialysis graftsResults. Full restoration of flow was established in 72 cases
and fistulae include mechanical thrombectomy, pharma-(88.9%). Early reobstruction within 14 days occurred in eight
comechanical thrombolysis, and percutaneous infusioncases (11.1%). Primary patency rates after a 1-, 3-, 6-, and 12-
month period were 74, 63, 52, and 27%, respectively. Overall pharmacologic thrombolysis. According to the clinical
fistula patency was 75% after 3 months, 65% after 6 months, practice guidelines for vascular access by the National
51% after 12 months, and 22% after 24 months. Kidney Foundation [3], each institution should choose toConclusions. Acute thrombotic occlusion of native AV fis-
resolve thrombosis based on the expertise of the center.tulae is a major complication of hemodialysis. The results of
Treatment of thrombosis in arteriovenous (AV) graftstreatment are believed to be less successful than thrombosis
treatment in synthetic grafts. Our results, however, indicate is thought to offer better success rates than thrombosis
the efficacy of percutaneous treatment in native fistulae, and correction in native fistulae [3]. However, only few data
demonstrate comparable technical results and patency rates.
exist on the treatment of clotted native AV dialysis fistu-
lae. The present study provides follow-up data on 81
procedures performed percutaneously to determine theDysfunction of hemodialysis fistulae and grafts is a
efficacy of thrombolysis in acute obstruction of primaryproblem frequently encountered in hemodialysis pa-
AV fistulae in the hemodialysis patient.tients. Because the number of patients with end-stage
renal disease being treated by hemodialysis is rising
steadily [1], the choice of an adequate treatment tech- METHODS
nique to maintain vascular access is of growing impor- Fifty-four patients with 81 episodes of recently throm-
tance for the patient and his or her physician. Shunt bosed native AV fistulae were referred for percutaneous
thrombosis is a commonly observed severe complication, thrombectomy. As a general rule in our institution, pa-
tients with suspected shunt dysfunction are primarily
referred to the interventional radiologic department forKey words: hemodialysis access, stenosis, thrombosis, fistula, percuta-
neous treatment, dialysis fistula, vascular access. percutaneous treatment. All of the patients diagnosed
with acute thrombotic occlusion were included in thisReceived for publication June 7, 1999
study. There were 32 male and 22 female patients agedand in revised form September 1, 1999
Accepted for publication October 12, 1999 24 to 79 years (mean 54.3 years). The type of fistula
was a forearm radiocephalic Brescia-Cimino fistula in 50Ó 2000 by the International Society of Nephrology
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patients and an upper-arm brachiocephalic AV fistula obstructing the AV anastomosis (N 5 20), maceration
of the thrombus was attempted by balloon angioplastyin four patients. Fistula location was on the right side in
24 patients and on the left side in 30 patients. All patients alone. Treatment of a long-segment thrombosis of the
autologous AV fistula (N 5 60) was performed by me-had end-stage renal disease and were participating in
the long-term hemodialysis program. Before the inter- chanical thrombectomy with various devices in 58 cases,
including the Amplatz mechanical thrombectomy devicevention, written, informed consent about the planned
procedure was obtained. (Microvena, White Bear Lake, MN, USA; N 5 23), the
Hydrolyser catheter (Cordis Europe, Roden, The Neth-Treatment was performed on the same day fistula
thrombosis was diagnosed. The procedure was per- erlands; N 5 24), and combined use of these devices (N 5
11). In selected cases, a minibasket for percutaneousformed as an outpatient procedure in 52 and as an inpa-
tient procedure in 29 cases. removal of wall-adherent thrombi (Cook; N 5 3) and a
cutting balloon (Interventional Technologies, San Diego,Treatment outcomes were evaluated on the basis of
technical procedural success and patency after correction CA, USA; N 5 1) were used in addition to the previously
listed devices to improve the recanalization result.of the clotted fistula. Technical success was defined as
restoration of arterialized fistula flow after termination In two cases, fistula occlusion was treated by percuta-
neous pharmacomechanical thrombolysis with 10 to 12of the procedure. Primary patency was defined as main-
tained arterialized flow during follow-up. Primary pat- mg recombinant tissue plasminogen activator (rtPA) and
clot maceration with a 6 mm percutaneous transluminalency ended when reintervention was necessary because
of restenosis or rethrombosis. The overall fistula patency angioplasty (PTA) balloon.
In one patient with an occlusion of the proximal radialwas defined as the ability to use the fistula for hemodialy-
sis, including, if necessary and feasible, percutaneous artery, thrombolysis was performed with 15 mg rtPA
and subsequent PTA.repeat interventions. Primary and overall patency rates
were calculated by the means of the Kaplan–Meier life- Balloon dilation was regularly performed (N 5 56) to
table analysis. Follow-up was performed by clinical ex- either treat an underlying stenosis or compress residual
amination and by monitoring the dialysis protocols. In thrombus material. Balloon catheter size was usually 5
the case of abnormal clinical findings and/or deviant dial- to 7 3 20 or 40 mm. Four 3 20 mm balloons were chosen
ysis data suggesting fistula failure, repeat angiography for angioplasty close to the AV anastomosis. No special
was indicated. If rethrombosis was demonstrated, recan- technique was applied to prevent potential central embo-
alization was attempted. lization, since the 7-F introducer sheath sufficiently
Fistula pathology was visualized by puncturing the blocked the venous outflow for larger emboli. During
brachial artery with a 22-gauge sheath needle (Abbott, the mechanical thrombectomy maneuver, the AV anas-
Sligo, Ireland) for arteriovenography. This approach was tomosis was digitally compressed to avoid retrograde
used to monitor the intervention in all procedures. Then thrombus dislodgment.
a tourniquet was applied for passive vein congestion to Periprocedural parenteral anticoagulation was admin-
select a venous puncture site by palpation, thus avoiding istered regularly at the beginning of the intervention
puncture of a clotted or stenosed segment. In selected (5000 IU heparin). After the procedure was terminated,
cases, additional Doppler ultrasound was performed. continued heparinization was recommended with 1000
The outflow vein was punctured in a retrograde fashion IU/h for at least 24 hours for inpatients and three subcu-
against the flow direction with the use of local anesthesia taneous 7500 IU injections during 24 hours in outpa-
and a 16-gauge sheath needle (Abbott), which was ex- tients.
changed for a 7-F introducer sheath (Terumo, Tokyo,
Japan) after dilation of the puncture site up to 7 F. The
RESULTSoccluded segment was passed with a 5-F multipurpose
Entrance into the thrombosed fistula was successfullycatheter (Cook, Bjaeverskov, Denmark) and a hydro-
performed in all 81 instances. Initial fistula salvage withphilic-coated and steerable 0.035-inch guide wire (Ter-
restoration of flow was established in 72 of 81 (88.9%)umo) across the anastomosis until the arterial segment
attempts (Figs. 1 and 2). Thirty-six of the 54 patientswas reached. Additional antegrade distal venous punc-
underwent declotting once, and 10 patients were treatedture for treatment of an upstream venous stenosis was
twice. Three or more episodes of thrombosis occurredperformed in 12 cases. In four patients with a brachio-
in eight patients with up to four episodes.cephalic upper arm fistula, the protocol was modified by
The estimated maximum occlusion time was 25 6 12antegrade puncture close to the anastomosis.
hours. The length of the thrombosed segment rangedThe type of treatment was chosen depending on loca-
from 1 to 40 cm (mean 22 6 17). Involvement of thetion of the occlusion and clot size observed by angiog-
distal radial artery was observed once.raphy.
In cases of a very short plug-like thrombus selectively Basically, there were three groups of patients in this
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Fig. 1. Digital subtraction angiography demonstrates a complete occlusion of the fistula draining vein at the arteriovenous anastomosis (arrow).
Fig. 2. Angiogram after mechanical thrombectomy with the Amplatz device and PTA. Recanalized fistula with excellent postprocedural flow
(arrows) is shown.
study: one group with an arterial thrombosis (N 5 1), were not able to break up sufficiently. In one case, the
intervention had to be abandoned because of severeone group with a short-segment thrombus (N 5 20), and
one group with a long-segment thrombosis (N 5 60). In pain; venous perforation at the puncture site with consec-
utive hematoma required surgical thrombectomy in onethe 20 cases with a short thrombus and in the patient
with an arterial fistula occlusion, arterialized flow was case. The estimated amount of residual thrombus was
23% (5 to 50% range). By combining the chosen mechan-completely re-established in all of the procedures
(100%). ical thrombectomy device (N 5 58) or the thrombolytic
agent (N 5 2) with PTA and in four cases, an additionalTechnical failure occurred in 9 of 60 cases (15%) in
the group with a long-segment thrombosis, and was con- application of a minibasket and cutting balloon, arterial-
ized flow was re-established in 51 cases. The results ofsidered to be due to older plug-like thrombus material
in seven cases that the mechanical thrombectomy devices the various mechanical devices used in this group did
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Table 1. Treatment results for mechanical thrombectomy tients (63%) until the end of the observation period or
devices (N 5 58)
the patient’s death. The remaining patients were lost to
No. of
Technical 3 month follow-up or underwent renal transplantation at some
procedures
success patency rate point in the observation period.
Device % There was no local procedure-related bleeding at the
Amplatz TD 23 82.6 67.3 catheter site. Venous dissection necessitating stent place-
Hydrolyser catheter 24 83.3 64.1 ment occurred in three cases (3.7%). The thrombectomyDevice combination 11 91.0 62.2
procedure itself was successfully performed in these
three instances, and the fistulas have remained patent
for at least six months. When advancing an angioplasty
catheter across the stenotic anastomosis in a patient with
a forearm fistula after a first Hydrolyser run, emboliza-
tion into the distal radial artery was observed. The embo-
lus was easily retrieved by insertion of a minibasket in-
side a 3-F catheter (Cook) across the anastomosis to the
more proximal part of the radial artery via the 7-F sheath.
The embolus was dislodged into the fistula vein and
subsequently removed with hydrodynamic thrombec-
tomy.
No clinical signs of pulmonary embolism with reports
of chest pain, shortness of breath, and pleurisy were
seen, and no other major complications were found.
Kaplan–Meier survival curves are displayed in Figure
3. With the inclusion of initial failures, primary patency
was calculated as 74% after 1 month (SE 5.6%), 63%
after 3 months (SE 6.1%), 52% after 6 months (SEFig. 3. Follow-up findings of the life-table analysis depicting the pri-
mary (h) and overall (r) patency rates. 6.3%), and 27% after 12 months (SE 6.6%). The median
duration of primary access patency was 8.1 6 11.5
months. The overall fistula patency was 75% at 3 months
(SE 6.6%), 65% at 6 months (SE 7.3%), 51% at 12
not differ significantly using the two-tailed Fisher’s exact months (7.7%), and 22% at 24 months (SE 8.4%).
test (P 5 1.000; Table 1).
If percutaneous thrombectomy failed, creation of a
DISCUSSIONnew fistula was performed in two cases. Surgical throm-
bus extraction was tried in seven, but failed in three Early detection and treatment of complications are
cases. A new fistula had to be created in these patients. essential to achieve long-term access function for the
The thrombectomy procedures in 54 fistulas were fol- hemodialysis patient. Thrombosis of dialysis grafts and
lowed from 1 day to 51 months with a mean follow-up fistulae represents a frequent complication [4]. Predis-
of 13 months 6 14.3 months. In the early stages of this posing factors are an underlying stenosis or aneurysmatic
study, we were concerned about a possible reduction of vein causing flow turbulences [5, 6], as well as arterial
blood flow from the needles in place, and therefore, hypotension, low cardiac output, compromised arterial
postprocedural hemodialysis was performed via a Shal- inflow, and clotting disorders [7]. In the vast majority of
don catheter in 36 cases to avoid early rethrombosis. cases, a venous stenosis is detected [6]. Surgical, as well
However, there were no findings supporting our theory, as percutaneous, procedure results have demonstrated
and this approach was discontinued. Thirty episodes of their effectiveness in graft recanalization. However, pat-
reocclusion occurred within the observation period. ency rates of percutaneous and surgical techniques are
Early rethrombosis within 14 days of thrombectomy was difficult to compare, as percutaneous interventions are
seen in eight cases (11.1%). Hypercoagulability, hypo- followed beginning with the initial procedure, whereas
tension, and stenosis were the assumed cause of early surgical studies generally report patency starting from
thrombosis. Thirty-two patients had no observed fistula the time of access creation. In a retrospective comparison
rethrombosis since the initial thrombectomy treatment. of surgical and percutaneous treatment for graft throm-
In addition, a total of 48 episodes of restenosis was noted, bosis, Sands et al performed 75 surgical thrombectomies
which were successfully treated by percutaneous balloon and 71 percutaneous pharmacomechanical procedures
angioplasty in all instances. Taking reinterventions into and observed no significant differences in success rates,
primary patencies, and rate of complications [8]. Beath-consideration, the fistula remained open in 34 of 54 pa-
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ard described equal initial success rates of mechanical chanical thrombectomy range from 75 to 94% with pri-
mary patencies of 18 to 39% at 6 months. Reportedthrombolysis compared with surgical thrombectomy [9].
Studies on surgical treatment of thrombosed native fis- 6- and 12-month secondary patencies for thrombolysis
range from 62 to 80% and 57 to 69%, respectively. Trero-tulae are rare. Diskin et al demonstrated a mean access
survival of 244 days after surgery in 45 patients with tola et al recently reported a 95% technical success with
a three-month primary patency of 39% using the newlynative fistulas [10]. Wehrli, Chenevard, and Zaruba re-
ported a success rate of 81.2% in patients with thrombo- developed Arrow-Trerotola percutaneous thrombolytic
device [25].sis of a newly created dialysis access [11]. Romero et al
found an almost 50% cumulative patency at two years Both the percutaneous and the surgical approach to
thrombosed AV fistulas remain difficult, partly becauseafter creation of a proximal new fistula caused by late
thrombosis [12]. Dapunt et al compared the results of of the pronounced organization of thrombus material in
native vessels. In many centers, patients with an occluded37 transluminal angioplasties with those of 37 operations
in the treatment of stenoses and occlusions of dialysis native fistula are referred for surgical thrombectomy.
However, because of anatomic reasons, the surgeon of-fistulae [13]. Cumulative patency after 12 months was
31.3% for angioplasty and 19.3% for surgery. ten prefers to perform a patch insertion or fistula reanas-
tomosis instead of mechanical thrombectomy. Our re-One limitation of the surgical approach is the lack
of imaging guidance in the operating room to detect sults with technical success rates of almost 90% and a
primary and overall fistula patency of 27% and 51% atadditional stenoses and obtain information on the often
complex vessel anatomy. Conversely, performance of one year, respectively, demonstrate the effectiveness of
percutaneous thrombosis treatment strategies in nativesurgical thrombectomy in the radiologic laboratory re-
quires a considerable amount of organization and man- fistulas. It is our workgroup’s opinion that as long as less
invasive comparable therapeutic options to preserve thepower. A solely percutaneous approach is therefore a
cost-reducing, attractive alternative. In recent years, per- vessel are available and feasible, abandonment of the
vascular access requiring an AV neoanastomosis shouldcutaneous interventional techniques have been tried and
established as a viable alternative means in the manage- be avoided, and a percutaneous approach should be con-
sidered.ment of fistula dysfunction. Zaleski et al reported on
17 patients with complete thrombosis of their Brescia- Generally, declotting should be performed as an out-
patient procedure. In two thirds of our cases, the proce-Cimino fistulas, which were treated by angioplasty and
urokinase infusion [14]. Procedural success was 82% with dure was performed on an outpatient basis, avoiding
general anesthesia and hospitalization, thus reducing theprimary, primary assisted, and secondary patency rates
at 12 months of 71, 93, and 100%, respectively. Poulain treatment risks and costs. The remaining one third of
the cases were inpatients, who had been primarily admit-et al combined a local low-dose infusion of urokinase
with PTA and thromboaspiration to achieve a 12-month ted to the hospital because of nonfistula-related prob-
lems.overall patency in 14 native fistulas of approximately
90% [15]. Twenty out of 24 patients (83%) with occluded We prefer to perform fistulography in native fistulas
via the brachial artery for several reasons. Arterial andBrescia-Cimino fistulas were successfully declotted by
Overbosch et al, employing the Hydrolyser catheter [16]. venous angiomorphology can be evaluated without plac-
ing a blood pressure cuff on the upper arm and inflatingThe median assisted patency was 34 weeks and was sig-
nificantly shorter in fistulas than in polytetrafluorolethy- the cuff to a suprasystolic pressure. This procedure can
be painful for the patient and lead to involuntary move-lene (PTFE) grafts (P 5 0.002). Turmel-Rodrigues et al
described an 81% initial success rate using thromboaspir- ments of the extremity, aggravating satisfactory shunt
visualization and documentation. The blood pressureation and PTA in 16 patients [17]. An 81% secondary
patency at one year was reported. Comparable results, cuff has to be left up for as short as possible to avoid
thrombosis. In addition, judgment of flow velocity andhowever, with far less patients, have been demonstrated
by various workgroups [18–23]. The reported technical spontaneous filling of collaterals, indicating the hemody-
namic significance of stenoses and occlusions, is impairedsuccess rates are similar to our own, whereas our patency
rates are less than those of Zaleski et al, Poulain et al, with the cuff inflated, especially at the AV anastomosis.
If necessary, the percutaneous intervention is monitoredand Turmel-Rodrigues et al, and are rather comparable
to those of Overbosch et al. These results suggest that easily from the arterial access; also, the procedural out-
come can be documented after catheter removal. Com-percutaneous interventions in occluded native AV fistu-
las are at least as effective as surgical treatment regarding plications of arterial puncture are rare. In a retrospective
analysis of 454 transbrachial arteriographies, we havetechnical success and patencies.
Treatment results of thrombosis and associated steno- observed one episode (0.2%) of significant bleeding at
the puncture site [26].sis in synthetic grafts have been summarized by Aruny
et al [24]. Clinical success rates for thrombolysis or me- It is advisable to perform the intervention as soon
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